Edwards Lifesciences (EW) Tops Q3 EPS by 2c; Guides Q4 EPS Below Views
Tweet Send to a Friend
Edwards Lifesciences Corp. (NYSE: EW) reported Q3 EPS of $0.68, $0.02 better than the analyst estimate ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
